OR5AU1 activators engage in a variety of mechanisms to increase the functional activity of this olfactory receptor, primarily through the modulation of intracellular cyclic adenosine monophosphate (cAMP) levels. Certain activators function by stimulating adenylate cyclase directly, thus elevating cAMP, which is a crucial second messenger in the signaling pathway that leads to OR5AU1 activation. Other activators inhibit the activity of phosphodiesterases, enzymes responsible for the degradation of cAMP, resulting in its accumulation within the cell. This sustained increase in cAMP levels amplifies the signaling cascade, culminating in the heightened activity of OR5AU1. Additionally, specific activators are odorant molecules that bind directly to OR5AU1, triggering its conformational change and subsequent activation, an essential process for the detection of odorants.
The activation landscape of OR5AU1 is further influenced by various neurotransmitters and hormones that interact with their respective receptors, leading to the downstream effect of increased cAMP production and OR5AU1 activation. For instance, catecholamines, through their interaction with beta-adrenergic receptors, and nucleosides like adenosine, through their engagement with adenosine receptors, both contribute to the elevation of cAMP levels. Prostanoids also play a role in the indirect activation of OR5AU1 by interacting with cell surface receptors that signal through cAMP.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX is a non-specific inhibitor of phosphodiesterases, increasing cAMP by preventing its breakdown, which in turn can activate OR5AU1 through the cAMP signaling pathway. | ||||||
(−)-Epinephrine | 51-43-4 | sc-205674 sc-205674A sc-205674B sc-205674C sc-205674D | 1 g 5 g 10 g 100 g 1 kg | $41.00 $104.00 $201.00 $1774.00 $16500.00 | ||
As a hormone and a neurotransmitter, stimulates adenylate cyclase activity, leading to increased cAMP levels, subsequently activating OR5AU1. | ||||||
L-Noradrenaline | 51-41-2 | sc-357366 sc-357366A | 1 g 5 g | $326.00 $485.00 | 3 | |
Activates adenylate cyclase, thereby increasing cAMP levels and activating OR5AU1 through the same pathway. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Isoproterenol is a synthetic catecholamine that acts on beta-adrenergic receptors to increase intracellular cAMP, indirectly activating OR5AU1. | ||||||
Histamine, free base | 51-45-6 | sc-204000 sc-204000A sc-204000B | 1 g 5 g 25 g | $94.00 $283.00 $988.00 | 7 | |
Histamine can increase cAMP production through its action on H2 receptors, which may result in the activation of OR5AU1. | ||||||
Dopamine | 51-61-6 | sc-507336 | 1 g | $290.00 | ||
Dopamine can increase cAMP levels by stimulating D1-like dopamine receptors, indirectly leading to the activation of OR5AU1. | ||||||
PGE2 | 363-24-6 | sc-201225 sc-201225C sc-201225A sc-201225B | 1 mg 5 mg 10 mg 50 mg | $57.00 $159.00 $275.00 $678.00 | 37 | |
PGE2 interacts with E-prostanoid receptors that can increase intracellular cAMP levels, thereby potentially activating OR5AU1. | ||||||
Adenosine | 58-61-7 | sc-291838 sc-291838A sc-291838B sc-291838C sc-291838D sc-291838E sc-291838F | 1 g 5 g 100 g 250 g 1 kg 5 kg 10 kg | $34.00 $48.00 $300.00 $572.00 $1040.00 $2601.00 $4682.00 | 1 | |
Adenosine, through its action on A2A and A2B receptors, increases cAMP levels, which could lead to the activation of OR5AU1. | ||||||
Caffeine | 58-08-2 | sc-202514 sc-202514A sc-202514B sc-202514C sc-202514D | 50 g 100 g 250 g 1 kg 5 kg | $33.00 $67.00 $97.00 $192.00 $775.00 | 13 | |
By acting as a non-selective antagonist of adenosine receptors, Caffeine leads to increased cAMP levels, which may in turn activate OR5AU1. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
As a selective inhibitor of phosphodiesterase 4 (PDE4), Rolipram raises cAMP levels in the cell, which could result in the activation of OR5AU1. | ||||||